Release Date: 26/04/17 12:03 Summary: Appendix 4C - quarterly Price Sensitive: Yes Download Document 211.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%